Biotia
Biotia Raises $9M to Close the Diagnostic Gap for Recurrent and Culture-Negative UTIs
Awamu mpya za ufadhili wa startup kutoka nyaraka za Form D za SEC na habari za teknolojia. Awamu zinazofuatiliwa: 558. Imesasishwa 15 Okt 2026.
Biotia Raises $9M to Close the Diagnostic Gap for Recurrent and Culture-Negative UTIs
Denmark’s Breye Therapeutics raises €67.5 million to advance oral therapies for early treatment of retinal diseases
Sweden’s Omnio raises €2.9 million to advance its plasminogen-based therapy for hard-to-heal chronic wounds
Form D: zimeuzwa $300K kati ya $641M zilizotolewa · Wawekezaji: 2
Form D: zimeuzwa $11M kati ya $11.7M zilizotolewa · Wawekezaji: 40
Form D: zimeuzwa $915K kati ya $973K zilizotolewa · Wawekezaji: 4 · waraka uliorekebishwa
Form D: zimeuzwa $25M · Wawekezaji: 10
Amsterdam’s preventive HealthTech Blue Health Intelligence raises €3.4 million to expand across Europe
Form D: zimeuzwa $8.09M kati ya $10.8M zilizotolewa · Wawekezaji: 82 · waraka uliorekebishwa
Forus Raises $150M to Close the Gap Between a Prescription and a First Dose
Tiny Health Raises $33M To Explore What Gut Data Can Reveal About Future Health
Form D: zimeuzwa $400K kati ya $1M zilizotolewa · Wawekezaji: 5 · waraka uliorekebishwa
Form D: zimeuzwa $50K kati ya $150K zilizotolewa · Wawekezaji: 1
Form D: zimeuzwa $9.56M · Wawekezaji: 15
Form D: zimeuzwa $1.5M · Wawekezaji: 1
Form D: zimeuzwa $4.03M kati ya $6.95M zilizotolewa · Wawekezaji: 17
Form D: zimeuzwa $50.5M kati ya $55M zilizotolewa · Wawekezaji: 36
Form D: zimeuzwa $1.7M · Wawekezaji: 22
Form D: zimeuzwa $1.86M · Wawekezaji: 1